Peripheral artery and bypass graft thrombolysis with recombinant human tissue-type plasminogen activator
- 1 January 1986
- journal article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 3 (1) , 115-124
- https://doi.org/10.1016/0741-5214(86)90074-1
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Local thrombolysis in the treatment of thrombosed arteries, bypass grafts, and arteriovenous fistulasJournal of Vascular Surgery, 1985
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.Circulation, 1984
- Coronary thrombolysis with recombinant human tissue-type plasminogen activator.Circulation, 1984
- Low-dose streptokinase for selective thrombolysis: systemic effects and complications.Radiology, 1984
- Coronary Thrombolysis with Tissue-Type Plasminogen Activator in Patients with Evolving Myocardial InfarctionNew England Journal of Medicine, 1984
- Coronary thrombolysis with intravenously administered human tissue-type plasminogen activator produced by recombinant DNA technology.Circulation, 1984
- Cloning and expression of human tissue-type plasminogen activator cDNA in E. coliNature, 1983
- Low dose streptokinase in the treatment of arterial occlusionsAmerican Journal of Roentgenology, 1981
- Purification and partial characterization of plasminogen activator from human uterine tissueBiochimica et Biophysica Acta (BBA) - Protein Structure, 1979
- The sulphite precipitation method for fibrinogen measurement; Its use on small samples in the presence of fibrinogen degradation productsClinica Chimica Acta; International Journal of Clinical Chemistry, 1976